Literature DB >> 18077522

18F-FDG PET as a routine test for posttherapy assessment of Hodgkin's disease and aggressive non-Hodgkin's lymphoma: where is the evidence?

Malik E Juweid1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18077522     DOI: 10.2967/jnumed.107.046292

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


× No keyword cloud information.
  4 in total

1.  Assessment of the nature of residual masses at end of treatment in lymphoma patients using volume perfusion computed tomography.

Authors:  R Syha; L Grünwald; T Horger; D Spira; D Ketelsen; W Vogel; C D Claussen; M Horger
Journal:  Eur Radiol       Date:  2013-12-05       Impact factor: 5.315

2.  Diffuse Large B-Cell Lymphoma: Prospective Multicenter Comparison of Early Interim FLT PET/CT versus FDG PET/CT with IHP, EORTC, Deauville, and PERCIST Criteria for Early Therapeutic Monitoring.

Authors:  Ryogo Minamimoto; Luis Fayad; Ranjana Advani; Julie Vose; Homer Macapinlac; Jane Meza; Jordan Hankins; Felix Mottaghy; Malik Juweid; Andrew Quon
Journal:  Radiology       Date:  2016-02-08       Impact factor: 11.105

3.  Diagnostic role of 18F-fluorodeoxyglucose positron emission tomography for follicular lymphoma with gastrointestinal involvement.

Authors:  Masaya Iwamuro; Hiroyuki Okada; Katsuyoshi Takata; Katsuji Shinagawa; Shigeatsu Fujiki; Junji Shiode; Atsushi Imagawa; Masashi Araki; Toshiaki Morito; Mamoru Nishimura; Motowo Mizuno; Tomoki Inaba; Seiyu Suzuki; Yoshinari Kawai; Tadashi Yoshino; Yoshiro Kawahara; Akinobu Takaki; Kazuhide Yamamoto
Journal:  World J Gastroenterol       Date:  2012-11-28       Impact factor: 5.742

4.  18-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in the Management of Aggressive Non-Hodgkin's B-Cell Lymphoma.

Authors:  M J Shelly; S McDermott; O J O'Connor; M A Blake
Journal:  ISRN Hematol       Date:  2012-03-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.